Phase 2 Study of Multi-Cancer Detection from Breath Samples
Jun 11, 2026 - 20:18
Radio and PodcastLive Radio & Podcasts
Science & Medicine
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma
JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper " Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Re...
Related Episodes
Continue listening to more episodes from Journal of Clinical Oncology (JCO) Podcast.
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
Jun 1, 2026 - 12:05
JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC
May 31, 2026 - 08:56
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
May 29, 2026 - 13:08
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
May 14, 2026 - 20:04
Infections in Two Diet Strategies in HSCT and Leukemia Patients
Apr 9, 2026 - 20:40